MedTrace Logo

It's Not JUST Idiopathic Pulmonary Fibrosis Study

NCT03670576 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2021-07-02

No results posted yet for this study

Summary

Study of progression of fibrosis in ILD

Conditions

Interventions

PROCEDURE

Optional Bronchoscopy

Patients can decide to have an optional bronchoscopy so that samples can be taken for research up to three months from baseline.

OTHER

Quality of Life Questionnaires

MRC Dyspnoea, SPARC, KBILD and EQ-5D-5L will be administered at baseline, 3 months, 12 months and 24 months,

OTHER

Blood Samples for Biomarkers

a 40ml research blood sample to be taken at baseline, 3 months, 12 months and 24 months.

OTHER

Home Hand Held Spirometry

Patients will download an app and are given a small hand held device to record their own spirometry at home. This is blinded for the first three months of the study and then requested a week before and a week after the three follow up points (3m, 12m, 24m)

Sponsors & Collaborators

  • Nottingham University Hospitals NHS Trust

    collaborator OTHER

  • University of Nottingham

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-11
Primary Completion
2022-11-11
Completion
2022-11-11

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03670576 on ClinicalTrials.gov